Free Trial

Jaguar Animal Health (JAGX) Competitors

Jaguar Animal Health logo
$1.60 -0.17 (-9.60%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$1.68 +0.08 (+4.69%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JAGX vs. LEXX, BLRX, ATHA, ADAP, EDSA, IMNN, MTVA, NEUP, PRPH, and ALLR

Should you be buying Jaguar Animal Health stock or one of its competitors? The main competitors of Jaguar Animal Health include Lexaria Bioscience (LEXX), BioLineRx (BLRX), Athira Pharma (ATHA), Adaptimmune Therapeutics (ADAP), Edesa Biotech (EDSA), Imunon (IMNN), MetaVia (MTVA), Neuphoria Therapeutics (NEUP), ProPhase Labs (PRPH), and Allarity Therapeutics (ALLR). These companies are all part of the "pharmaceutical products" industry.

Jaguar Animal Health vs. Its Competitors

Lexaria Bioscience (NASDAQ:LEXX) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

In the previous week, Lexaria Bioscience and Lexaria Bioscience both had 1 articles in the media. Jaguar Animal Health's average media sentiment score of 0.75 beat Lexaria Bioscience's score of 0.63 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company Overall Sentiment
Lexaria Bioscience Positive
Jaguar Animal Health Positive

Lexaria Bioscience currently has a consensus price target of $4.00, indicating a potential upside of 349.44%. Jaguar Animal Health has a consensus price target of $60.00, indicating a potential upside of 3,650.00%. Given Jaguar Animal Health's higher probable upside, analysts plainly believe Jaguar Animal Health is more favorable than Lexaria Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lexaria Bioscience
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Jaguar Animal Health
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Lexaria Bioscience has higher earnings, but lower revenue than Jaguar Animal Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lexaria Bioscience$460K37.84-$5.80M-$0.67-1.33
Jaguar Animal Health$11.69M0.30-$38.49MN/AN/A

Lexaria Bioscience has a beta of 0.79, suggesting that its stock price is 21% less volatile than the S&P 500. Comparatively, Jaguar Animal Health has a beta of 0.43, suggesting that its stock price is 57% less volatile than the S&P 500.

13.1% of Lexaria Bioscience shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 26.4% of Lexaria Bioscience shares are owned by insiders. Comparatively, 4.6% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Jaguar Animal Health has a net margin of -344.16% compared to Lexaria Bioscience's net margin of -1,849.19%. Lexaria Bioscience's return on equity of -157.22% beat Jaguar Animal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Lexaria Bioscience-1,849.19% -157.22% -133.69%
Jaguar Animal Health -344.16%-660.18%-77.42%

Summary

Lexaria Bioscience beats Jaguar Animal Health on 6 of the 11 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JAGX vs. The Competition

MetricJaguar Animal HealthMED IndustryMedical SectorNASDAQ Exchange
Market Cap$3.85M$2.51B$5.78B$9.79B
Dividend YieldN/A1.68%3.95%4.02%
P/E RatioN/A22.8231.2626.59
Price / Sales0.30550.77436.91155.84
Price / CashN/A177.0937.7359.36
Price / Book0.796.1810.736.68
Net Income-$38.49M$32.94M$3.27B$265.59M
7 Day Performance-11.11%-0.78%1.42%0.62%
1 Month Performance-26.94%2.77%6.21%2.61%
1 Year Performance-94.29%12.01%51.81%22.34%

Jaguar Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JAGX
Jaguar Animal Health
2.2663 of 5 stars
$1.60
-9.6%
$60.00
+3,650.0%
-94.3%$3.85M$11.69M0.0050High Trading Volume
LEXX
Lexaria Bioscience
3.7847 of 5 stars
$0.84
+2.1%
$4.00
+378.2%
-69.5%$16.03M$460K-1.257
BLRX
BioLineRx
3.396 of 5 stars
$3.83
+3.2%
$26.00
+578.9%
-85.9%$15.81M$28.94M-0.4440Gap Up
ATHA
Athira Pharma
3.7628 of 5 stars
$0.39
-1.9%
$0.50
+27.3%
-88.0%$15.80MN/A-0.2540Positive News
ADAP
Adaptimmune Therapeutics
1.8708 of 5 stars
$0.07
+17.6%
$1.35
+1,831.0%
-94.4%$15.77M$65.09M-0.11490High Trading Volume
EDSA
Edesa Biotech
2.2169 of 5 stars
$2.31
+3.4%
$5.00
+116.9%
-44.7%$15.73MN/A-1.7520Positive News
Gap Down
High Trading Volume
IMNN
Imunon
1.7422 of 5 stars
$6.48
+1.3%
$232.50
+3,488.0%
-64.7%$15.62M$500K-0.5030Gap Up
MTVA
MetaVia
2.0807 of 5 stars
$0.65
+1.7%
$7.50
+1,052.8%
N/A$15.49MN/A0.008Gap Up
NEUP
Neuphoria Therapeutics
2.0091 of 5 stars
$7.79
-3.8%
$21.00
+169.6%
N/A$15.23M$10K0.00N/ANews Coverage
Analyst Forecast
Analyst Revision
PRPH
ProPhase Labs
1.4333 of 5 stars
$0.33
-4.4%
N/A-85.2%$14.51M$6.77M-0.27130Positive News
ALLR
Allarity Therapeutics
2.9685 of 5 stars
$0.91
-5.0%
$9.00
+889.0%
-67.9%$14.45MN/A0.0010

Related Companies and Tools


This page (NASDAQ:JAGX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners